Symptomatic bradycardia complicating the use of intravenous dipyridamole for thallium-201 myocardial perfusion imaging

Int J Cardiol. 1990 May;27(2):272-4. doi: 10.1016/0167-5273(90)90170-a.

Abstract

Intravenous dipyridamole was given for routine thallium-201 myocardial perfusion imaging. The patient developed chest discomfort followed by cardiovascular collapse with sinus arrest and a nodal escape rhythm at 28 beats per minute. He was rapidly resuscitated without adverse sequelae. A reversible posteroinferior perfusion defect and proximal right coronary artery occlusion were found. Symptomatic bradycardia after dipyridamole may be mediated by ischaemia.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bradycardia / chemically induced*
  • Depression, Chemical
  • Dipyridamole / administration & dosage
  • Dipyridamole / adverse effects*
  • Heart / diagnostic imaging*
  • Heart Rate / drug effects
  • Humans
  • Infusions, Intravenous
  • Male
  • Middle Aged
  • Radionuclide Imaging
  • Thallium Radioisotopes

Substances

  • Thallium Radioisotopes
  • Dipyridamole